during this period , norepinephrine-stimulated ffa release increased 50 % above -1 month rates , epinephrine-stimulated ffa release increased 128 % , and norepinephrine- and epinephrine-stimulated glycerol release increased 30 and 87 % , respectively .
C0028351
norepinephrine
C0014563
epinephrine